Resources

Infertility Treatment Market

Future Market Insights

Provides information on global infertility treatment market size, growth forecasts, key segments, regional trends, leading companies, and technological advancements for strategic decision-making.

Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer

Singh, S. et al.

Summarizes sex-based differences in chemotherapy toxicity, response rates, and survival outcomes in small-cell lung cancer to inform treatment considerations.

Innovation in Sexual and Reproductive Health Series

The Lancet

Collection of articles summarizing global trends, innovations, and cost-effectiveness in sexual and reproductive health to guide optimal resource use and improve health outcomes worldwide.

Innovation in Women’s Health 2025

Silicon Valley Bank

Provides data and analysis on women’s health investment trends, market growth, care gaps, and innovation to inform investors, startups, and healthcare stakeholders.

Integrating sex and gender into health and care research

NIHR

Provides information on integrating sex and gender into health and care research to improve outcomes and address research gaps and inequalities.

Intersectionality, Gender Norms, And Young Adolescents In Context: A Review Of Longitudinal Multi-country Research Programs To Shape Future Action

Banati et al.

Reviews data on how gender norms intersect with other disadvantages to shape adolescent health, providing recommendations for designing effective interventions and research.

Iron and Folic Acid Supplementation in Pregnancy: Findings from the Baseline Assessment of a Maternal Nutrition Service Programme in Bangladesh

Billah et al.

Provides data on iron and folic acid supplementation coverage, adherence, and influencing factors among pregnant women in rural Bangladesh to inform program improvements.

Is Sex as a Biological Variable Still Being Ignored in Preclinical Aging Research?

Carmody, C. et al.

Reviews adherence to NIH mandates on sex as a biological variable in preclinical aging research, identifying gaps and recommending strategies for improved compliance.

Is this the new era? Funding for sexual & reproductive health R&D 2018-2023

Impact Global Health

Summarizes global funding trends, gaps, and priorities in sexual and reproductive health R&D from 2018-2023, to inform investment and policy decisions.

Landscape of Diagnostics Development for Preterm Labour, Pre-eclampsia & Intrauterine Growth Restriction

Impact Global Health

Summarizes the global development pipeline and status of diagnostics for preterm labour, preeclampsia, and intrauterine growth restriction to guide R&D priorities.

Landscape of Medicines Development for Five Pregnancy-Related Conditions 2000-2021

Impact Global Health

Summarizes medicines development for five pregnancy-related conditions (2000-2021) to inform research, policy, and investment decisions.

Leading and Sustaining Curricular Change: Workshop Proceedings From the 2018 Sex and Gender Health Education Summit

Templeton, K. et al.

Summarizes strategies, resources, and outcomes for implementing and sustaining sex and gender health topics in health professions curricula through interprofessional workshops.

Let’s Talk About Sex – Biological Sex Is Underreported in Biomaterials Studies

James, B. D. et al.

Summarizes the lack of biological sex reporting in biomaterial studies and highlights its importance for developing precision, sex-specific healthcare materials.

Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects

Hassall et al.

Reviews current and emerging techniques for clinical antimicrobial resistance diagnosis, highlighting limitations and the need for standardisation to improve rapid, accurate detection.

Making Pharmaceutical Research and Regulation Work for Women

Ravindran, T. S. et al.

Reviews gaps in sex and gender integration in pharmaceutical research, regulation, and policy to highlight the need for more equitable, evidence-based approaches for women.

Market Demand for Noncommunicable Disease Drugs and Diagnostics

The Defeat-NCD Partnership

Summarizes market demand, availability, and affordability gaps for non-communicable disease drugs and diagnostics in LMICs to inform procurement and policy decisions.

Market Failure and the Poverty of New Drugs in Maternal Health

Fisk, N. M. & Atun, R. 

Summarizes the lack of pharmaceutical R&D for maternal health, reviews causes, and discusses implications for global health policy and drug development priorities.

Maternal health pipeline

Impact Global Health

Profiles and tracks medicines, diagnostics, and devices for seven major pregnancy-related conditions to inform maternal health R&D investment and development decisions.